705 related articles for article (PubMed ID: 27083389)
1. MicroRNA223 promotes pathogenic T-cell development and autoimmune inflammation in central nervous system in mice.
Satoorian T; Li B; Tang X; Xiao J; Xing W; Shi W; Lau KH; Baylink DJ; Qin X
Immunology; 2016 Aug; 148(4):326-38. PubMed ID: 27083389
[TBL] [Abstract][Full Text] [Related]
2. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Interferon Regulatory Factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.
Yang C; He D; Yin C; Tan J
Scand J Immunol; 2015 Oct; 82(4):345-51. PubMed ID: 26110284
[TBL] [Abstract][Full Text] [Related]
4. 1,25-dihydroxyvitamin D
Xie Z; Chen J; Zheng C; Wu J; Cheng Y; Zhu S; Lin C; Cao Q; Zhu J; Jin T
Immunology; 2017 Nov; 152(3):414-424. PubMed ID: 28617989
[TBL] [Abstract][Full Text] [Related]
5. Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses.
Quan MY; Song XJ; Liu HJ; Deng XH; Hou HQ; Chen LP; Ma TZ; Han X; He XX; Jia Z; Guo L
J Neuroinflammation; 2019 Mar; 16(1):52. PubMed ID: 30823934
[TBL] [Abstract][Full Text] [Related]
6. LFA-1 Controls Th1 and Th17 Motility Behavior in the Inflamed Central Nervous System.
Dusi S; Angiari S; Pietronigro EC; Lopez N; Angelini G; Zenaro E; Della Bianca V; Tosadori G; Paris F; Amoruso A; Carlucci T; Constantin G; Rossi B
Front Immunol; 2019; 10():2436. PubMed ID: 31681316
[TBL] [Abstract][Full Text] [Related]
7. Absence of Notch1 in murine myeloid cells attenuates the development of experimental autoimmune encephalomyelitis by affecting Th1 and Th17 priming.
Fernández M; Monsalve EM; López-López S; Ruiz-García A; Mellado S; Caminos E; García-Ramírez JJ; Laborda J; Tranque P; Díaz-Guerra MJM
Eur J Immunol; 2017 Dec; 47(12):2090-2100. PubMed ID: 28762472
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
[TBL] [Abstract][Full Text] [Related]
9. STEAP4 expression in CNS resident cells promotes Th17 cell-induced autoimmune encephalomyelitis.
Zhao J; Liao Y; Miller-Little W; Xiao J; Liu C; Li X; Li X; Kang Z
J Neuroinflammation; 2021 Apr; 18(1):98. PubMed ID: 33879167
[TBL] [Abstract][Full Text] [Related]
10. Conditional DC depletion does not affect priming of encephalitogenic Th cells in EAE.
Isaksson M; Lundgren BA; Ahlgren KM; Kämpe O; Lobell A
Eur J Immunol; 2012 Oct; 42(10):2555-63. PubMed ID: 22806332
[TBL] [Abstract][Full Text] [Related]
11. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
[TBL] [Abstract][Full Text] [Related]
12. A natural flavonoid glucoside icariin inhibits Th1 and Th17 cell differentiation and ameliorates experimental autoimmune encephalomyelitis.
Shen R; Deng W; Li C; Zeng G
Int Immunopharmacol; 2015 Feb; 24(2):224-231. PubMed ID: 25528476
[TBL] [Abstract][Full Text] [Related]
13. P2Y
Li Z; He C; Zhang J; Zhang H; Wei H; Wu S; Jiang W
J Immunol; 2020 Jul; 205(2):387-397. PubMed ID: 32554432
[TBL] [Abstract][Full Text] [Related]
14. IFN-β regulates Th17 differentiation partly through the inhibition of osteopontin in experimental autoimmune encephalomyelitis.
Zhao Q; Cheng W; Xi Y; Cao Z; Xu Y; Wu T; Li C; Niu X; Chen G
Mol Immunol; 2018 Jan; 93():20-30. PubMed ID: 29127843
[TBL] [Abstract][Full Text] [Related]
15. Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance.
Álvarez-Sánchez N; Cruz-Chamorro I; López-González A; Utrilla JC; Fernández-Santos JM; Martínez-López A; Lardone PJ; Guerrero JM; Carrillo-Vico A
Brain Behav Immun; 2015 Nov; 50():101-114. PubMed ID: 26130320
[TBL] [Abstract][Full Text] [Related]
16. Cutting Edge: MicroRNA-223 Regulates Myeloid Dendritic Cell-Driven Th17 Responses in Experimental Autoimmune Encephalomyelitis.
Ifergan I; Chen S; Zhang B; Miller SD
J Immunol; 2016 Feb; 196(4):1455-1459. PubMed ID: 26783338
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic Stimulation of Myeloid Antigen-Presenting Cells Attenuates Signal Transducer and Activator of Transcription 3-Activation Favouring the Development of Experimental Autoimmune Encephalomyelitis.
Prado C; Gaiazzi M; González H; Ugalde V; Figueroa A; Osorio-Barrios FJ; López E; Lladser A; Rasini E; Marino F; Zaffaroni M; Cosentino M; Pacheco R
Front Immunol; 2018; 9():571. PubMed ID: 29619030
[TBL] [Abstract][Full Text] [Related]
18. Korean Red Ginseng and Ginsenoside-Rb1/-Rg1 Alleviate Experimental Autoimmune Encephalomyelitis by Suppressing Th1 and Th17 Cells and Upregulating Regulatory T Cells.
Lee MJ; Jang M; Choi J; Chang BS; Kim DY; Kim SH; Kwak YS; Oh S; Lee JH; Chang BJ; Nah SY; Cho IH
Mol Neurobiol; 2016 Apr; 53(3):1977-2002. PubMed ID: 25846819
[TBL] [Abstract][Full Text] [Related]
19. Interferon-β regulates dendritic cell activation and migration in experimental autoimmune encephalomyelitis.
Pennell LM; Fish EN
Immunology; 2017 Nov; 152(3):439-450. PubMed ID: 28646573
[TBL] [Abstract][Full Text] [Related]
20. Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis.
Cummings M; Arumanayagam ACS; Zhao P; Kannanganat S; Stuve O; Karandikar NJ; Eagar TN
PLoS One; 2018; 13(8):e0200752. PubMed ID: 30089166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
